Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2009 1
2011 1
2012 3
2013 10
2014 8
2015 1
2016 16
2017 15
2018 11
2019 10
2020 17
2021 12
2022 13
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Pereira IAG, Freitas CS, Câmara RSB, Jesus MM, Lage DP, Tavares GSV, Soyer TG, Ramos FF, Soares NP, Santiago SS, Martins VT, Vale DL, Pimenta BL, Ludolf F, Oliveira FM, Duarte MC, Chávez-Fumagalli MA, Costa AV, Gonçalves DU, Roatt BM, Teixeira RR, Coelho EAF. Pereira IAG, et al. Among authors: roatt bm. Exp Parasitol. 2024 Mar 19;260:108743. doi: 10.1016/j.exppara.2024.108743. Online ahead of print. Exp Parasitol. 2024. PMID: 38513973
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
Freitas CS, Pereira IAG, Lage DP, Vale DL, Pimenta BL, Soares NP, Santiago SS, Martins VT, Câmara RSB, Jesus MM, Tavares GSV, Ramos FF, Ludolf F, Magalhães LND, Oliveira FM, Duarte MC, Chávez-Fumagalli MA, Costa AV, Roatt BM, Teixeira RR, Coelho EAF. Freitas CS, et al. Among authors: roatt bm. Cytokine. 2024 May;177:156543. doi: 10.1016/j.cyto.2024.156543. Epub 2024 Feb 18. Cytokine. 2024. PMID: 38373365
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Jesus MM, Lage DP, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, Ludolf F, Tavares GSV, Galdino AS, Duarte MC, Menezes-Souza D, Chávez-Fumagalli MA, Teixeira AL, Gonçalves DU, Roatt BM, Christodoulides M, Martins VT, Coelho EAF. Jesus MM, et al. Among authors: roatt bm. Parasitol Res. 2023 Dec;122(12):2917-2931. doi: 10.1007/s00436-023-07981-6. Epub 2023 Sep 28. Parasitol Res. 2023. PMID: 37768367
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
Lage DP, Martins VT, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, de Jesus MM, Ludolf F, Tavares GSV, Chávez-Fumagalli MA, Roatt BM, Christodoulides M, Coelho EAF. Lage DP, et al. Among authors: roatt bm. Acta Trop. 2023 Oct;246:106986. doi: 10.1016/j.actatropica.2023.106986. Epub 2023 Jul 14. Acta Trop. 2023. PMID: 37453579
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
Vale DL, Freitas CS, Martins VT, Moreira GJL, Machado AS, Ramos FF, Pereira IAG, Bandeira RS, de Jesus MM, Tavares GSV, Ludolf F, Chávez-Fumagalli MA, Galdino AS, Fujiwara RT, Bueno LL, Roatt BM, Christodoulides M, Coelho EAF, Lage DP. Vale DL, et al. Among authors: roatt bm. Biology (Basel). 2023 Jun 13;12(6):851. doi: 10.3390/biology12060851. Biology (Basel). 2023. PMID: 37372136 Free PMC article.
The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection.
Mathias FAS, Ostolin TLVDP, Reis LES, Cardoso JMO, De Brito RCF, Aguiar Soares RDO, Roatt BM, Vieira PMA, Reis AB. Mathias FAS, et al. Vaccines (Basel). 2023 Feb 9;11(2):395. doi: 10.3390/vaccines11020395. Vaccines (Basel). 2023. PMID: 36851272 Free PMC article.
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.
Soyer TG, Ramos FF, Pereira IAG, Lage DP, Bandeira RS, de Jesus MM, Costa GP, Machado AS, Freitas CS, Vale DL, Martins VT, Galdino AS, Chávez-Fumagalli MA, Menezes-Souza D, Duarte MC, Roatt BM, Coelho EAF, Tavares GSV. Soyer TG, et al. Among authors: roatt bm. Pathogens. 2023 Feb 14;12(2):314. doi: 10.3390/pathogens12020314. Pathogens. 2023. PMID: 36839586 Free PMC article.
Immunoproteomics approach for the discovery of antigens applied to the diagnosis of canine visceral leishmaniasis.
Costa SS, Santos LMO, Freire LC, Tedeschi ALF, Ribeiro NR, Queiroz MHR, Neto EB, Pimenta DC, Galvani NC, Luiz GP, de Oliveira ME, de Ávila RAM, Carvalho AMRS, Brigido BVS, Reis AB, Fernandes APSM, Coelho EAF, Roatt BM, Menezes-Souza D, Duarte MC. Costa SS, et al. Acta Trop. 2023 May;241:106865. doi: 10.1016/j.actatropica.2023.106865. Epub 2023 Feb 12. Acta Trop. 2023. PMID: 36787861
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Freitas CS, Lage DP, Machado AS, Vale DL, Martins VT, Cardoso JMO, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Ramos FF, Ludolf F, Pereira IAG, Bandeira RS, Fujiwara RT, Bueno LL, Roatt BM, Chávez-Fumagalli MA, Coelho EAF. Freitas CS, et al. Among authors: roatt bm. Cytokine. 2023 Apr;164:156143. doi: 10.1016/j.cyto.2023.156143. Epub 2023 Feb 10. Cytokine. 2023. PMID: 36774730
114 results